Trial
NCT05368506
ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
OHSU Knight Cancer Institute
Collaborators
Oregon Health and Science University
Condition
Advanced Fallopian Tube Carcinoma
Intervention
Wee1 Inhibitor ZN-c3
Why stopped
PI discretion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-06